- Home
- JMM vs PYXS Comparison
JMM vs PYXS Comparison
Compare JMM & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- PYXS
- Stock Information
- Founded
- JMM 1988
- PYXS 2018
- Country
- JMM United States
- PYXS United States
- Employees
- JMM N/A
- PYXS N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- JMM Finance
- PYXS Health Care
- Exchange
- JMM Nasdaq
- PYXS Nasdaq
- Market Cap
- JMM 58.5M
- PYXS 66.3M
- IPO Year
- JMM N/A
- PYXS 2021
- Fundamental
- Price
- JMM $6.19
- PYXS $1.17
- Analyst Decision
- JMM
- PYXS Strong Buy
- Analyst Count
- JMM 0
- PYXS 5
- Target Price
- JMM N/A
- PYXS $9.00
- AVG Volume (30 Days)
- JMM 16.1K
- PYXS 405.6K
- Earning Date
- JMM 01-01-0001
- PYXS 08-13-2025
- Dividend Yield
- JMM 5.44%
- PYXS N/A
- EPS Growth
- JMM N/A
- PYXS N/A
- EPS
- JMM N/A
- PYXS N/A
- Revenue
- JMM N/A
- PYXS N/A
- Revenue This Year
- JMM N/A
- PYXS N/A
- Revenue Next Year
- JMM N/A
- PYXS N/A
- P/E Ratio
- JMM N/A
- PYXS N/A
- Revenue Growth
- JMM N/A
- PYXS N/A
- 52 Week Low
- JMM $5.29
- PYXS $0.83
- 52 Week High
- JMM $6.10
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- JMM 50.23
- PYXS 46.51
- Support Level
- JMM $6.06
- PYXS $1.14
- Resistance Level
- JMM $6.27
- PYXS $1.41
- Average True Range (ATR)
- JMM 0.09
- PYXS 0.08
- MACD
- JMM -0.01
- PYXS -0.02
- Stochastic Oscillator
- JMM 54.55
- PYXS 12.73
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.